IOC Editorial & Medical Information TeamPrepared with more than 22 years of bariatric-centre experience and checked against the official sources listed below. See our review process.
Instructions from your own surgical or prescribing team take priority over this general guide. Contact local emergency care for severe or rapidly worsening symptoms.
Key takeaways
- Brand popularity does not establish a clinical indication.
- Trial averages cannot predict one person's result or side effects.
- Compare long-term monitoring, supply, cost and alternatives—not only the first prescription.
The brand name is not the treatment plan
Prescription injections differ by active substance, authorised indication, dosing schedule, evidence and safety profile. Examples include tirzepatide, semaglutide and liraglutide products, but not every brand is authorised for weight management.
Selection should start with diagnosis and eligibility, not price, online popularity or a promised number of kilograms.
What effectiveness numbers can and cannot tell you
Clinical-trial averages describe groups under defined conditions. They cannot predict one person’s result. Dose tolerance, adherence, related disease, nutrition, activity, sleep and ongoing support all affect outcomes.
A responsible plan defines when response will be reviewed, what monitoring is needed and what happens if benefit is insufficient or side effects are unacceptable.
Long-term questions to ask
Before starting, ask who will prescribe and monitor treatment, how genuine medicine will be supplied, which tests are required, how side effects are handled and what the plan is if treatment stops.
- Is the product authorised for my diagnosis?
- How will diabetes medicines and other prescriptions be adjusted?
- What nutrition and resistance-exercise support will protect health and lean mass?
- When should medication, endoscopic treatment or surgery be reconsidered?
Compare pathways, not advertisements
Medication, endoscopic therapy and bariatric surgery can all be appropriate in selected people. The safest comparison is personalised and includes expected benefit, risk, duration, reversibility, cost over time and the required follow-up.
See every obesity treatment pathway
Compare medication, endoscopic therapies and bariatric procedures in one structured directory.
Open treatment pageFrequently asked questions
Which injection is most effective?
Trial averages differ, but the right medicine is the one authorised and clinically suitable for the individual, with acceptable risk and monitoring.
Are all GLP-1 brands approved for weight loss?
No. Authorised indications differ by product and jurisdiction even when active substances are related.
Will weight return when an injection stops?
Regain can occur. Before starting, discuss the maintenance plan, expected duration and alternatives with the prescriber.
Can injections and bariatric surgery be compared directly?
They differ in eligibility, effect, duration, risk and follow-up. A personalised clinical comparison is more useful than advertising claims.
Sources
This article was checked against the following official clinical and regulatory sources at its latest update.
European Medicines Agency — MounjaroEuropean Medicines Agency — WegovyEuropean Medicines Agency — Saxenda
